| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/1997 | EP0752856A1 Methods of treating hyperlipidemia |
| 01/15/1997 | EP0752854A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 01/15/1997 | EP0752851A1 New pharmaceutical formulation and process |
| 01/15/1997 | EP0752850A1 Pharmaceutical formulation |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0752847A1 Ophthalmic composition with decreased viscosity |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0752838A1 STABLE SUPPOSITORY FORMULATIONS EFFECTING BIOVAILABILITY OF $g(D)?9 -THC |
| 01/15/1997 | EP0752813A1 Inhibitors of metazoan parasite proteases |
| 01/15/1997 | EP0693926B1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/15/1997 | EP0663907B1 Method of preparing taxane derivatives |
| 01/15/1997 | EP0642528B1 Phosphotriester-type biologically active compounds |
| 01/15/1997 | EP0625986B1 Oligothionucleotides |
| 01/15/1997 | EP0625178B1 Improved processes for the manufacture of enriched pitches and carbon fibers |
| 01/15/1997 | EP0595995B1 Arylamidoalkyl- and arylaminoalkyl-n-hydroxyurea compounds and -n-hydroxyformamide derivatives having lipoxygenase inhibitory activity |
| 01/15/1997 | EP0594770B1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
| 01/15/1997 | EP0588857B1 Insecticide composition |
| 01/15/1997 | EP0584091B1 Benzopyranones, methods of manufacture and use thereof |
| 01/15/1997 | EP0571457B1 Iloprost effective against cerebral malaria |
| 01/15/1997 | EP0539484B1 Method for preparing sulphonylpristinamycin iib |
| 01/15/1997 | EP0519971B1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE |
| 01/15/1997 | EP0514451B1 Dietary supplements comprising vitamins and minerals |
| 01/15/1997 | EP0495919B1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs |
| 01/15/1997 | EP0495831B1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 01/15/1997 | EP0478694B1 use of pirenzepine, telenzepine oder O-methoxy -sila-hexocyclium in the manufacture of a medicament for the TREATMENT AND CONTROL OF OCULAR DEVELOPMENT |
| 01/15/1997 | EP0473708B1 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives |
| 01/15/1997 | EP0427827B1 8-alpha-ACYLAMINO-ERGOLINES, THEIR PREPARATION AND USE AS DRUGS |
| 01/15/1997 | CN1140453A 3'-substd. nucleoside derivs. |
| 01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
| 01/15/1997 | CN1140448A New compounds with analgesic and local anaesthetic effect |
| 01/15/1997 | CN1140447A Novel carbamate deriv. and medicinal composition contg. the same |
| 01/15/1997 | CN1140412A Percutaneously absorbable preparation |
| 01/15/1997 | CN1140411A Oral liquid compositions contg. paroxetine resinate |
| 01/15/1997 | CN1140410A Vitamin E and derivs. preventing damage in red cells sterilized by phthalocyanines and light |
| 01/15/1997 | CN1140409A Treatment of normotensive glaucoma with angiotensin II antagonisto |
| 01/15/1997 | CN1140407A Process for preparing solid pharmaceutical dosage forms |
| 01/15/1997 | CN1140406A Oil-in-water emulsions |
| 01/15/1997 | CN1140178A Use of new steroid compound for preparing medicaments |
| 01/15/1997 | CN1140175A 7-acyl-3-(substd. carbamoyloxy) cephem compounds and their preparation process |
| 01/15/1997 | CN1140174A Piperidine derivatives, process for preparation thereof and application thereof in therapeutics |
| 01/15/1997 | CN1140173A Novel pyrido |3,2-e¨ pyrazinones with anti-asthmatic action and processes for their manufacture |
| 01/15/1997 | CN1140172A Cyclic compounds, their production and use |
| 01/15/1997 | CN1140171A Benzofurans |
| 01/15/1997 | CN1140170A Preparative liquid chromatography for extracting and purifying taxol and other taxanes derivs |
| 01/15/1997 | CN1140167A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/15/1997 | CN1140164A Antiarrhythmic and cardioprotective substituted indenoyiguanidines |
| 01/15/1997 | CN1140091A Bitterness-relieving agent |
| 01/15/1997 | CN1140059A Process for preparing pharmaceutical composition contg. new steroid compounds |
| 01/15/1997 | CN1140058A Slow-release microsphere powder injection of androgenic hormone, its preparing method and use |
| 01/15/1997 | CN1140057A Treatment of optic nerve disorder with prostanoic acid compounds |
| 01/15/1997 | CN1140056A Medicinal film for preventing and treating dermatomycosis pedis |
| 01/15/1997 | CN1140053A Cosmetic for skin |
| 01/15/1997 | CN1033809C Novel a-nor-steroid-3-carboxylic acid derivs. preparation method |
| 01/15/1997 | CN1033808C Process for preparing steroids substd. omega-phenylamino alkanoic acids and their salts |
| 01/15/1997 | CN1033790C Process for stabilizing omeprazole and benzimidazole derivs |
| 01/15/1997 | CN1033789C Process for preparing jellied bismuth tartrate medicine |
| 01/14/1997 | US5594157 Process for making taxol derivatives |
| 01/14/1997 | US5594154 5-amino-2-bromomethyl-2,4,6,7-tetramethyl-2,3-dihydrobenzo(b) furans |
| 01/14/1997 | US5594144 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 01/14/1997 | US5594140 Imidazo[1,5-A]quinolines for treatment of anxiety and sleep disorders |
| 01/14/1997 | US5594139 From 5-hal-2,6-diamino-3h-4-oxopyrimidine |
| 01/14/1997 | US5594138 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans |
| 01/14/1997 | US5594135 Bactericides |
| 01/14/1997 | US5594133 Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropinonyloxy)-ethyl-3-cephem-4-carboxylate |
| 01/14/1997 | US5594132 7-acylamino-3-substituted cephalosporanic acid derivatives |
| 01/14/1997 | US5594122 Bind to conserved regions of human immunodeficiency virus genetic material to prevent expression thereof |
| 01/14/1997 | US5594034 Method of inhibiting gastric acid secretion with 8-substituted-2-amino-1,2,3,4-tetrahydronapthalene |
| 01/14/1997 | US5594033 Cardiovascular disorders |
| 01/14/1997 | US5594032 Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
| 01/14/1997 | US5594031 Methods and compositions for the treatment of the skin |
| 01/14/1997 | US5594030 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/14/1997 | US5594027 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents |
| 01/14/1997 | US5594025 Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane |
| 01/14/1997 | US5594024 Centrally actig substituted phenylazacycloalkanes |
| 01/14/1997 | US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5594019 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles |
| 01/14/1997 | US5594015 Thiazolidine derivatives for the treatment of psoriasis |
| 01/14/1997 | US5594014 Indole derivatives as 5-HT1 agonists |
| 01/14/1997 | US5594013 Polyvinylpyrrolidone and an acrylic polymer, slow release |
| 01/14/1997 | US5594010 Treatment of hypertension and atheriosclerosis |
| 01/14/1997 | US5594008 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 01/14/1997 | US5594005 Use of quinoline-3-carboxamide compounds for treatment of diabetes |
| 01/14/1997 | US5594004 Compound with platelet aggregation inhibitor activity |
| 01/14/1997 | US5594003 Hypotensive agents |
| 01/14/1997 | US5593995 Treatment of psychoses and psychological disorders; analgesics |
| 01/14/1997 | US5593994 Prostaglandin synthase inhibitors |
| 01/14/1997 | US5593993 Method for inhibition of HIV related viruses |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593989 Tetracyclic 1,4-oxazine compounds |
| 01/14/1997 | US5593987 Methods of inhibiting breast disorders |
| 01/14/1997 | US5593986 Cephalosporin antibiotics |
| 01/14/1997 | US5593985 Cephalosporin compounds |
| 01/14/1997 | US5593984 Cephalosporin derivatives |
| 01/14/1997 | US5593983 Preparation by reacting substituted /thio/morpholine or salt and 2,3-epoxyandrostane or 2,3-epoxy-19-nor-androstane; use to induce anesthesia |
| 01/14/1997 | US5593982 Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders |
| 01/14/1997 | US5593981 Method and treatment of androgen-related diseases |